Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 654

1.

Prothrombotic factors and the risk of acute onset non-cardioembolic stroke in young Asian Indians.

Biswas A, Ranjan R, Meena A, Akhter S, Sharma V, Yadav BK, Behari M, Saxena R.

Thromb Res. 2009 Sep;124(4):397-402. doi: 10.1016/j.thromres.2009.02.015. Epub 2009 Jun 27.

PMID:
19560187
2.

Factor V Leiden: is it the chief contributor to activated protein C resistance in Asian-Indian patients with deep vein thrombosis?

Biswas A, Bajaj J, Ranjan R, Meena A, Akhter MS, Yadav BK, Sharma V, Saxena R.

Clin Chim Acta. 2008 Jun;392(1-2):21-4. doi: 10.1016/j.cca.2008.02.018. Epub 2008 Feb 25.

PMID:
18342013
3.

Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies.

Chopra N, Koren S, Greer WL, Fortin PR, Rauch J, Fortin I, Senécal JL, Docherty P, Hanly JG.

J Rheumatol. 2002 Aug;29(8):1683-8.

PMID:
12180730
4.

Factor V Leiden and prothrombin gene mutation may predispose to paradoxical embolism in subjects with patent foramen ovale.

Karttunen V, Hiltunen L, Rasi V, Vahtera E, Hillbom M.

Blood Coagul Fibrinolysis. 2003 Apr;14(3):261-8.

PMID:
12695749
5.

Prevalence of factor V Leiden and prothrombin G20210A mutations in Chinese patients with deep venous thrombosis and pulmonary embolism.

Jun ZJ, Ping T, Lei Y, Li L, Ming SY, Jing W.

Clin Lab Haematol. 2006 Apr;28(2):111-6.

PMID:
16630215
6.

Lower contribution of factor V Leiden or G202104 mutations to ischemic stroke in patients with clinical risk factors: pair-matched case-control study.

Eterović D, Titlić M, Culić V, Zadro R, Primorac D.

Clin Appl Thromb Hemost. 2007 Apr;13(2):188-93.

PMID:
17456629
7.

[Significance of Factor V gene A506G mutation (Leiden) in the pathogenesis of ischemic stroke].

Pongrácz E, Tordai A, Csornai M, Béla Z, Nagy Z.

Ideggyogy Sz. 2003 May 20;56(5-6):157-64. Hungarian.

PMID:
12861956
8.

Association of factor V Leiden mutation with delayed graft function, acute rejection episodes and long-term graft dysfunction in kidney transplant recipients.

Hocher B, Slowinski T, Hauser I, Vetter B, Fritsche L, Bachert D, Kulozik A, Neumayer HH.

Thromb Haemost. 2002 Feb;87(2):194-8.

PMID:
11858477
9.

Survey of factor V leiden and prothrombin gene mutations in systemic lupus erythematosus.

Topaloglu R, Akierli C, Bakkaloglu A, Aydintug O, Ozen S, Besbas N, Ozcelik T.

Clin Rheumatol. 2001;20(4):259-61.

PMID:
11529632
10.

Combined heterozygous plasminogen deficiency and factor V Leiden defect in the same kindred.

Sartori MT, Simioni P, Patrassi GM, Theodoridis P, Tormene D, Girolami A.

Clin Appl Thromb Hemost. 2000 Jan;6(1):36-40.

PMID:
10726047
11.

[Prothrombotic factors in stroke].

Meseguer E, Llamas P, Fernández de Velasco J, García A, Echevarria A, Oña R, Rábano J, Tomas JF, García de Yébenes J.

Neurologia. 2004 Apr;19(3):99-105. Spanish.

PMID:
15088159
12.

Prevalence of hyperhomocysteinaemia, activated protein C resistance and prothrombin gene mutation in inflammatory bowel disease.

Mahmood A, Needham J, Prosser J, Mainwaring J, Trebble T, Mahy G, Ramage J.

Eur J Gastroenterol Hepatol. 2005 Jul;17(7):739-44.

PMID:
15947551
13.

Factor V Leiden and prothrombin gene G20210A mutations are uncommon in portal vein thrombosis in India.

Sharma S, Kumar SI, Poddar U, Yachha SK, Aggarwal R.

Indian J Gastroenterol. 2006 Sep-Oct;25(5):236-9.

PMID:
17090840
14.

Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study.

El-Karaksy H, El-Koofy N, El-Hawary M, Mostafa A, Aziz M, El-Shabrawi M, Mohsen NA, Kotb M, El-Raziky M, El-Sonoon MA, A-Kader H.

Ann Hematol. 2004 Nov;83(11):712-5. Epub 2004 Aug 10. Erratum in: Ann Hematol. 2005 Mar;84(3):205.

PMID:
15309526
15.

Factor V Leiden and prothrombin gene G20210A mutations in ocular Behçet disease.

Batioğlu F, Atmaca LS, Karabulut HG, Beyza Sayin D.

Acta Ophthalmol Scand. 2003 Jun;81(3):283-5.

16.

Factor V Leiden and prothrombin gene G 20210 A variant in children with ischemic stroke.

Zenz W, Bodó Z, Plotho J, Streif W, Male C, Bernert G, Rauter L, Ebetsberger G, Kaltenbrunner K, Kurnik P, Lischka A, Paky F, Ploier R, Höfler G, Mannhalter C, Muntean W.

Thromb Haemost. 1998 Nov;80(5):763-6.

PMID:
9843168
17.

Factor V Leiden mutation and other thrombophilia markers in childhood ischemic stroke.

Duran R, Biner B, Demir M, Celtik C, Karasalihoğlu S.

Clin Appl Thromb Hemost. 2005 Jan;11(1):83-8.

PMID:
15678277
18.

Coagulation factors II, V, VII, and X, prothrombin gene 20210G-->A transition, and factor V Leiden in coronary artery disease: high factor V clotting activity is an independent risk factor for myocardial infarction.

Redondo M, Watzke HH, Stucki B, Sulzer I, Biasiutti FD, Binder BR, Furlan M, Lämmle B, Wuillemin WA.

Arterioscler Thromb Vasc Biol. 1999 Apr;19(4):1020-5.

19.

[Factor V Leiden and prothrombin G20210A among Chilean patients with venous and arterial thrombosis].

Palomo I, Pereira J, Alarcón M, Pinochet C, Vélez MT, Hidalgo P, Skagerberg K, Poblete F.

Rev Med Chil. 2005 Dec;133(12):1425-33. Epub 2006 Jan 27. Spanish.

20.

Prevalence of antiphospholipid antibodies, factor V G1691A (Leiden) and prothrombin G20210A mutations in early and late recurrent pregnancy loss.

Mtiraoui N, Borgi L, Hizem S, Nsiri B, Finan RR, Gris JC, Almawi WY, Mahjoub T.

Eur J Obstet Gynecol Reprod Biol. 2005 Apr 1;119(2):164-70.

PMID:
15808373

Supplemental Content

Support Center